We found that the expression of c-Myc in HCC-TAMs was inhibited by either the silencing of Wnt2b expression (Fig. 6c) or by CpG ODN treatment (Fig. 6d; Supplementary Fig. 6F). The gene discussed is MYC; the disease is hepatocellular carcinoma.